| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $7.2M | +14.8% |
| R&D Expense | $1.6M | -8.8% |
| SG&A Expense | $12.0M | +2.8% |
| Operating Income | -$23.8M | +2.5% |
| Pre-tax Income | -$24.6M | -2.6% |
| Income Tax | $3K | +50.0% |
| Net Income | -$24.6M | -2.6% |
| EPS (Basic) | -$3.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -75.3% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $251K | -73.0% |
| Current Assets | $4.6M | -74.6% |
| Total Assets | $26.4M | -21.5% |
| Current Liabilities | $8.2M | +77.4% |
| Total Liabilities | $10.1M | +34.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | -326.9% |
| Capital Expenditures | $7.9M | +41.5% |
| Investing Cash Flow | -$11.6M | -18.6% |
| Financing Cash Flow | $12.8M | -42.9% |
| Free Cash Flow | -$21.6M | -145.2% |
| -1432.0% |
| Stockholders' Equity |
| $16.2M |
| -37.7% |